OPKO Health, Inc. (OPK) Q1 2026 Earnings Call Transcript
OPKO Health held its Q1 2026 earnings call on April 28, 2026, during which management reviewed financial results and business developments. The company highlighted ongoing operations and strategic initiatives while noting forward-looking statements subject to risks. Executives participated in the discussion, followed by questions from research analysts. No major financial figures or significant updates were detailed in the transcript excerpt.
- ▪OPKO Health's Q1 2026 earnings call took place on April 28, 2026, at 4:30 PM EDT.
- ▪Company executives, including Chairman & CEO Phillip Frost and President Elias Zerhouni, participated in the call.
- ▪Forward-looking statements were made, with reference to risks outlined in OPKO's SEC filings, including its 2025 Form 10-K.
- ▪Analysts from firms including Jefferies, JPMorgan, H.C. Wainwright, and Piper Sandler participated in the Q&A.
- ▪The transcript does not include specific financial results or material operational updates.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895464-opko-health-inc-opk-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.